Animal models for COVID-19.
Animals
Betacoronavirus
/ drug effects
COVID-19
COVID-19 Vaccines
Coronavirus Infections
/ drug therapy
Disease Models, Animal
Ferrets
/ virology
Humans
Mesocricetus
/ virology
Mice
Pandemics
/ prevention & control
Pneumonia, Viral
/ drug therapy
Primates
/ virology
SARS-CoV-2
Viral Vaccines
/ immunology
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
22
06
2020
accepted:
15
09
2020
pubmed:
24
9
2020
medline:
30
10
2020
entrez:
23
9
2020
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a novel coronavirus into humans late in 2019 (first detected in Hubei province, China). As of 18 September 2020, SARS-CoV-2 has spread to 215 countries, has infected more than 30 million people and has caused more than 950,000 deaths. As humans do not have pre-existing immunity to SARS-CoV-2, there is an urgent need to develop therapeutic agents and vaccines to mitigate the current pandemic and to prevent the re-emergence of COVID-19. In February 2020, the World Health Organization (WHO) assembled an international panel to develop animal models for COVID-19 to accelerate the testing of vaccines and therapeutic agents. Here we summarize the findings to date and provides relevant information for preclinical testing of vaccine candidates and therapeutic agents for COVID-19.
Identifiants
pubmed: 32967005
doi: 10.1038/s41586-020-2787-6
pii: 10.1038/s41586-020-2787-6
pmc: PMC8136862
mid: NIHMS1700241
doi:
Substances chimiques
COVID-19 Vaccines
0
Viral Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
509-515Subventions
Organisme : NIAID NIH HHS
ID : R01 AI157155
Pays : United States
Organisme : NIH HHS
ID : P51 OD011104
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148166
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI129269
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI060699
Pays : United States
Organisme : World Health Organization
ID : 001
Pays : International
Commentaires et corrections
Type : CommentIn
Références
Nature. 2020 Mar;579(7798):183
pubmed: 32152596
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):E3119-E3128
pubmed: 28348219
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
Science. 2020 May 29;368(6494):945-946
pubmed: 32385100
Science. 2005 Oct 28;310(5748):676-9
pubmed: 16195424
Nature. 2020 Sep;585(7824):273-276
pubmed: 32516797
Transbound Emerg Dis. 2020 Jul;67(4):1453-1462
pubmed: 32306500
Viruses. 2018 Dec 19;10(12):
pubmed: 30572566
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
Emerg Microbes Infect. 2020 Dec;9(1):2433-2445
pubmed: 33073694
Adv Cancer Res. 2012;115:69-92
pubmed: 23021242
Virology. 2015 May;479-480:259-70
pubmed: 25816764
JACC Case Rep. 2020 Jul 15;2(9):1315-1320
pubmed: 32292915
J Virol. 2007 Feb;81(3):1162-73
pubmed: 17108019
Emerg Infect Dis. 2004 May;10(5):914-6
pubmed: 15200830
Animal Model Exp Med. 2020 Mar 30;3(1):93-97
pubmed: 32318665
J Infect Dis. 2017 Dec 27;217(1):58-63
pubmed: 29087482
F1000Res. 2020 Jan 27;9:52
pubmed: 32419926
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
J Virol. 2008 Aug;82(15):7264-75
pubmed: 18495771
PLoS Genet. 2015 Oct 09;11(10):e1005504
pubmed: 26452100
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
N Engl J Med. 2020 Aug 6;383(6):592-594
pubmed: 32402157
Nature. 2018 Apr;556(7700):255-258
pubmed: 29618817
Science. 2020 Jul 3;369(6499):77-81
pubmed: 32376603
Cell. 2020 Aug 6;182(3):744-753.e4
pubmed: 32553273
Nat Commun. 2020 Jul 8;11(1):3496
pubmed: 32641684
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446
pubmed: 32215622
Science. 2014 Nov 21;346(6212):987-91
pubmed: 25359852
Emerg Infect Dis. 2005 Mar;11(3):446-8
pubmed: 15757562
Cell Host Microbe. 2020 Jul 8;28(1):124-133.e4
pubmed: 32485164
Emerg Infect Dis. 2004 Feb;10(2):179-84
pubmed: 15030680
Lancet Microbe. 2020 Sep;1(5):e218-e225
pubmed: 32838346
Cell Rep. 2020 Feb 11;30(6):1702-1713.e6
pubmed: 32049004
Euro Surveill. 2020 Jun;25(23):
pubmed: 32553059
Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8738-43
pubmed: 26124093
J Virol. 2014 Feb;88(4):2205-18
pubmed: 24335303
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
J Virol. 2018 Jan 30;92(4):
pubmed: 29212926
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595
pubmed: 32571934
Nat Microbiol. 2016 Nov 28;2:16226
pubmed: 27892925
Nat Commun. 2021 Jan 4;12(1):81
pubmed: 33398055
J Virol. 2007 Jan;81(2):813-21
pubmed: 17079315
Virus Res. 2008 Apr;133(1):74-87
pubmed: 17451830
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4970-5
pubmed: 24599590
Cell Host Microbe. 2020 May 13;27(5):704-709.e2
pubmed: 32259477
Nat Biotechnol. 2020 May;38(5):523-532
pubmed: 32203293
Science. 2020 May 29;368(6494):1012-1015
pubmed: 32303590
Nature. 2020 Jul;583(7818):830-833
pubmed: 32380511
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Physiol Rev. 2020 Jul 1;100(3):1065-1075
pubmed: 32216698
J Virol. 2020 Jul 16;94(15):
pubmed: 32404529
Nat Commun. 2020 Nov 17;11(1):5838
pubmed: 33203860
J Exp Med. 2020 Dec 7;217(12):
pubmed: 32750141
Front Immunol. 2019 Oct 01;10:2329
pubmed: 31632404
Science. 2020 Aug 14;369(6505):806-811
pubmed: 32434945
Science. 2020 Aug 14;369(6505):812-817
pubmed: 32434946
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
J Clin Microbiol. 2004 Jul;42(7):3196-206
pubmed: 15243082
J Virol. 2005 Jan;79(1):503-11
pubmed: 15596843
Nature. 2020 Sep;585(7824):268-272
pubmed: 32396922
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322
pubmed: 32826334
Viruses. 2020 Jul 20;12(7):
pubmed: 32698441
PLoS Pathog. 2020 May 22;16(5):e1008536
pubmed: 32442210